Wallvik, J., Stenke, L., Bernell, P., Nordahl, G., Hippe, E. and Hast, R. (2002) Serum Erythropoietin (EPO) Levels Correlate with Survival and Independently Predict Response to EPO Treatment in Patients with Myelodysplastic Syndromes. European Journal of Haematology, 68, 180-185.
http://dx.doi.org/10.1034/j.1600-0609.2002.01530.x

has been cited by the following article:

• TITLE: Quantification of the Erythropoietic Response to Anemia and Determination of the Hb × log(Epo) Component as an Independent Parameter, Indicating the Response to Hypoxic Stress

  AUTHORS: Argiris Symeonidis, Alexandra Kouraklis-Symeonidis, Vassiliki Labropoulou, Vasileios Lazaris, Paraskevi Katsaouni, Evgenia Verigou, Trifon Spiridonidis, Evangelia Tzouvara, Maria Tiniakou, Dimitris Apostolopoulos, Michalis Leotsinidis

  KEYWORDS: Erythropoietin, Hemoglobin, Anemia, Hypoxia, Response to Anemia

  JOURNAL NAME: Journal of Biomedical Science and Engineering, Vol.9 No.10, September 20, 2016

  ABSTRACT: Serum erythropoietin (Epo) levels are influenced by the integrity of renal function, the severity and etiology of anemia, the percentage of hemoglobin F and other factors. We aimed to create a parametric expression for the response to anemic/hypoxic stress and we evaluated serum Epo levels in 1096 subjects with normal renal function, of whom 837 were anemic (Hb 16.5 g/dl). Hb ranged between 3.6 and 23.8 g/dl and the corresponding Epo between